Spotlight: Psychedelic Therapy: A Primer for Primary Care Clinicians-- Ketamine (Evans, et al, 2024)
"Ketamine, an arylcyclohexylamine dissociative anesthetic agent, has evolved into a versatile therapeutic. It has a rapid-onset, well-understood cardiovascular effects and a favorable safety profile in clinical use"
Physicians are often not trained to consider the human experience of working with psychedelic medicines like ketamine in the sub-anesthetic, psychedelic dose range, often relying on the biological aspects of a molecule, forgetting the "assisted-psychgotherapy" that has traditionally accompanied medicine for mental health treatments for over 100 years.
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine - PubMed
Ketamine’s comprehensive clinical profile, combined with its robust effects on depression, suicidal ideation, PTSD, chronic pain, and other psychiatric conditions, positions it as a substantial contender for transformative therapeutic application.
Viviana D Evans
